{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T21:20:47Z","timestamp":1776288047772,"version":"3.50.1"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2016,1,25]],"date-time":"2016-01-25T00:00:00Z","timestamp":1453680000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Schmerz"],"published-print":{"date-parts":[[2016,2]]},"DOI":"10.1007\/s00482-015-0085-2","type":"journal-article","created":{"date-parts":[[2016,1,25]],"date-time":"2016-01-25T08:41:46Z","timestamp":1453711306000},"page":"25-36","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":31,"title":["Cannabinoide in der palliativen Versorgung","Cannabinoids in palliative care"],"prefix":"10.1007","volume":"30","author":[{"given":"M.","family":"M\u00fccke","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Carter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Cuhls","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Pr\u00fc\u00df","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Radbruch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W.","family":"H\u00e4user","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,1,25]]},"reference":[{"key":"85_CR1","doi-asserted-by":"crossref","unstructured":"Ablin J, St. Marie P, H\u00e4user W et\u00a0al (2016) Medical use of cannabis products. Lessons to be learned from Israel and Canada. Schmerz 30 (im Druck)","DOI":"10.1007\/s00482-015-0083-4"},{"key":"85_CR2","doi-asserted-by":"crossref","first-page":"258","DOI":"10.7326\/0003-4819-139-4-200308190-00008","volume":"139","author":"DI Abrams","year":"2003","unstructured":"Abrams DI, Hilton JF, Leiser RJ et\u00a0al (2003) Short-term effects of cannabinoids in patients with HIV-1 infection: a randomized, placebo-controlled clinical trial. Ann Intern Med 139:258\u2013266","journal-title":"Ann Intern Med"},{"key":"85_CR3","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/0885-3924(94)00117-4","volume":"10","author":"JE Beal","year":"1995","unstructured":"Beal JE, Olson R, Laubenstein L et\u00a0al (1995) Dronabinol as a treatment for anorexia associated with weight loss in patients with AIDS. J\u00a0Pain Symptom Manage 10:89\u201397","journal-title":"J\u00a0Pain Symptom Manage"},{"key":"85_CR4","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0885-3924(97)00038-9","volume":"14","author":"JE Beal","year":"1997","unstructured":"Beal JE, Olson R, Lefkowitz L et\u00a0al (1997) Long-term efficacy and safety of dronabinol for acquired immunodeficiency syndrome-associated anorexia. J\u00a0Pain Symptom Manage 14:7\u201314. doi: 10.1016\/S0885-3924(97)00038-9","journal-title":"J\u00a0Pain Symptom Manage"},{"key":"85_CR5","doi-asserted-by":"crossref","unstructured":"Bedi G, Foltin RW, Gunderson EW et\u00a0al (2010) Efficacy and tolerability of high-dose dronabinol maintenance in HIV-positive marijuana smokers: a controlled laboratory study. 212:675\u2013686. doi: 10.1007\/s00213-010-1995-4","DOI":"10.1007\/s00213-010-1995-4"},{"key":"85_CR6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13722-015-0032-7","volume":"10","author":"KA Belendiuk","year":"2015","unstructured":"Belendiuk KA, Baldini LL, Bonn-Miller MO (2015) Narrative review of the safety and efficacy of marijuana for the treatment of commonly state-approved medical and psychiatric disorders. Addict Sci Clin Pract 10:1\u201310. doi: 10.1186\/s13722-015-0032-7","journal-title":"Addict Sci Clin Pract"},{"key":"85_CR7","doi-asserted-by":"crossref","first-page":"2086","DOI":"10.1093\/annonc\/mdq727","volume":"22","author":"TD Brisbois","year":"2011","unstructured":"Brisbois TD, de Kock IH, Watanabe SM et\u00a0al (2011) Delta-9-tetrahydrocannabinol may palliate altered chemosensory perception in cancer patients: results of a randomized, double-blind, placebo-controlled pilot trial. Ann Oncol 22:2086\u20132093. doi: 10.1093\/annonc\/mdq727","journal-title":"Ann Oncol"},{"key":"85_CR8","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1097\/00004714-198306000-00004","volume":"3","author":"H Gross","year":"1983","unstructured":"Gross H, Ebert MH, Faden VB et\u00a0al (1983) A double-blind trial of delta 9-tetrahydrocannabinol in primary anorexia nervosa. J\u00a0Clin Psychopharmacol 3:165\u2013171","journal-title":"J\u00a0Clin Psychopharmacol"},{"key":"85_CR9","first-page":"495","volume":"109","author":"F Grotenhermen","year":"2012","unstructured":"Grotenhermen F, M\u00fcller-Vahl K (2012) The therapeutic potential of cannabis and cannabinoids. Dtsch Arztebl Int 109:495\u2013501. doi: 10.3238\/arztebl.2012.0495","journal-title":"Dtsch Arztebl Int"},{"key":"85_CR10","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1097\/QAI.0b013e31811ed205","volume":"45","author":"M Haney","year":"2007","unstructured":"Haney M, Gunderson EW, Rabkin J et\u00a0al (2007) Dronabinol and marijuana in HIV-positive marijuana smokers. Caloric intake, mood, and sleep. J\u00a0Acquir Immune Defic Syndr 45:545\u2013554. doi: 10.1097\/QAI.0b013e31811ed205","journal-title":"J\u00a0Acquir Immune Defic Syndr"},{"key":"85_CR11","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1007\/s00213-005-2242-2","volume":"181","author":"M Haney","year":"2005","unstructured":"Haney M, Rabkin J, Gunderson E, Foltin RW (2005) Dronabinol and marijuana in HIV(+) marijuana smokers: acute effects on caloric intake and mood. Psychopharmacology (Berl) 181:170\u2013178. doi: 10.1007\/s00213-005-2242-2","journal-title":"Psychopharmacology (Berl)"},{"key":"85_CR12","unstructured":"Higgins JP, Green S. Cochrane handbook for systematic reviews of interventions. http:\/\/handbook.cochrane.org\/ . Zugegriffen: 10.\u00a0Oktober 2015"},{"key":"85_CR13","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1200\/JCO.20.2.567","volume":"20","author":"A Jatoi","year":"2002","unstructured":"Jatoi A, Windschitl HE, Loprinzi CL et\u00a0al (2002) Dronabinol versus megestrol acetate versus combination therapy for cancer-associated anorexia: a North Central Cancer Treatment Group study. J\u00a0Clin Oncol 20:567\u2013573","journal-title":"J\u00a0Clin Oncol"},{"key":"85_CR14","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.jpainsymman.2009.06.008","volume":"39","author":"JR Johnson","year":"2010","unstructured":"Johnson JR, Burnell-Nugent M, Lossignol D et\u00a0al (2010) Multicenter, double-blind, randomized, placebo-controlled, parallel-group study of the efficacy, safety, and tolerability of THC:CBD extract and THC extract in patients with intractable cancer-related pain. J\u00a0Pain Symptom Manage 39:167\u2013179. doi: 10.1016\/j.jpainsymman.2009.06.008","journal-title":"J\u00a0Pain Symptom Manage"},{"key":"85_CR15","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1191\/026921699668963873","volume":"13","author":"MS Jordh\u00f8y","year":"1999","unstructured":"Jordh\u00f8y MS, Kaasa S, Fayers P et\u00a0al (1999) Challenges in palliative care research; recruitment, attrition and compliance: experience from a randomized controlled trial. Palliat Med 13:299\u2013310","journal-title":"Palliat Med"},{"key":"85_CR16","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1177\/0269216306072620","volume":"20","author":"S Kaasa","year":"2006","unstructured":"Kaasa S, Hjermstad MJ, Loge JH (2006) Methodological and structural challenges in palliative care research: how have we fared in the last decades? Palliat Med 20:727\u2013734. doi: 10.1177\/0269216306072620","journal-title":"Palliat Med"},{"key":"85_CR17","first-page":"CD005175","volume":"4","author":"EE Lutge","year":"2013","unstructured":"Lutge EE, Gray A, Siegfried N (2013) The medical use of cannabis for reducing morbidity and mortality in patients with HIV\/AIDS. Cochrane Database Syst Rev 4:CD005175","journal-title":"Cochrane Database Syst Rev"},{"key":"85_CR18","doi-asserted-by":"crossref","first-page":"e123","DOI":"10.2174\/1874306400903010123","volume":"3","author":"D Moher","year":"2009","unstructured":"Moher D, Liberati A, Tetzlaff J, Altman DG (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement. Open Med 3:e123\u2013e130","journal-title":"Open Med"},{"key":"85_CR19","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1002\/cpt197518184","volume":"18","author":"R Noyes","year":"1975","unstructured":"Noyes R, Brunk SF, Avery DA, Canter AC (1975) The analgesic properties of delta-9-tetrahydrocannabinol and codeine. Clin Pharmacol Ther 18:84\u201389","journal-title":"Clin Pharmacol Ther"},{"key":"85_CR20","first-page":"438","volume":"13","author":"RK Portenoy","year":"2012","unstructured":"Portenoy RK, Ganae-Motan ED, Allende S et\u00a0al (2012) Nabiximols for opioid-treated cancer patients with poorly-controlled chronic pain: a randomized, placebo-controlled, graded-dose trial. J\u00a0Pain 13:438\u2013449. doi: 10.1016\/j.jpain.2012.01.003","journal-title":"J\u00a0Pain"},{"key":"85_CR21","first-page":"763","volume-title":"Pharmacology of Marihuana","author":"W Regelson","year":"1976","unstructured":"Regelson W, Butler JR, Schulz J (1976) Delta-9-THC as an effective antidepressant and appetite-stimulating agent in advanced cancer patients. In: Braude MC, Szara S (Hrsg) Pharmacology of Marihuana. Raven Press, New York, S\u00a0763\u2013775"},{"key":"85_CR22","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1016\/j.ejca.2010.03.012","volume":"46","author":"KR Sigurdardottir","year":"2010","unstructured":"Sigurdardottir KR, Haugen DF, van der Rijt CCD et\u00a0al (2010) Clinical priorities, barriers and solutions in end-of-life cancer care research across Europe. Report from a workshop. Eur J Cancer 46:1815\u20131822. doi: 10.1016\/j.ejca.2010.03.012","journal-title":"Eur J Cancer"},{"key":"85_CR23","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1002\/cpt1978234397","volume":"23","author":"M Staquet","year":"1978","unstructured":"Staquet M, Gantt C, Machin D (1978) Effect of a nitrogen analog of tetrahydrocannabinol on cancer pain. Clin Pharmacol Ther 23:397\u2013401","journal-title":"Clin Pharmacol Ther"},{"key":"85_CR24","doi-asserted-by":"crossref","first-page":"3394","DOI":"10.1200\/JCO.2005.05.1847","volume":"24","author":"F Strasser","year":"2006","unstructured":"Strasser F (2006) Comparison of orally administered cannabis extract and delta-9-tetrahydrocannabinol in treating patients with cancer-related anorexia-cachexia syndrome: a multicenter, phase\u00a0III, randomized, double-blind, placebo-controlled clinical trial from the Cannabis-In-Cachexia-Study-Group. J\u00a0Clin Oncol 24:3394\u20133400. doi: 10.1200\/JCO.2005.05.1847","journal-title":"J\u00a0Clin Oncol"},{"key":"85_CR25","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1177\/106002809302700701","volume":"27","author":"M Struwe","year":"1993","unstructured":"Struwe M, Kaempfer SH, Geiger CJ et\u00a0al (1993) Effect of dronabinol on nutritional status in HIV infection. Ann Pharmacother 27:827\u2013831","journal-title":"Ann Pharmacother"},{"key":"85_CR26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/15563650.2015.1110590","volume":"54","author":"RJ Tait","year":"2015","unstructured":"Tait RJ, Caldicott D, Mountain D et\u00a0al (2015) A systematic review of adverse events arising from the use of synthetic cannabinoids and their associated treatment. Clin Toxicol (Phila) 54:1\u201313. doi: 10.3109\/15563650.2015.1110590","journal-title":"Clin Toxicol (Phila)"},{"key":"85_CR27","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1089\/aid.1997.13.305","volume":"13","author":"JG Timpone","year":"1997","unstructured":"Timpone JG, Wright DJ, Li N et\u00a0al (1997) The safety and pharmacokinetics of single-agent and combination therapy with megestrol acetate and dronabinol for the treatment of HIV wasting syndrome. AIDS Res Hum Retroviruses 13:305\u2013315. doi: 10.1089\/aid.1997.13.305","journal-title":"AIDS Res Hum Retroviruses"},{"key":"85_CR28","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1002\/(SICI)1099-1166(199709)12:9<913::AID-GPS663>3.0.CO;2-D","volume":"12","author":"L Volicer","year":"1997","unstructured":"Volicer L, Stelly M, Morris J et\u00a0al (1997) Effects of dronabinol on anorexia and disturbed behavior in patients with Alzheimer\u2019s disease. Int J Geriatr Psychiatry 12:913\u2013919. doi:10.1002\/(SICI)1099-1166(199709)12:9<913::AID-GPS663>3.0.CO;2-D","journal-title":"Int J Geriatr Psychiatry"},{"key":"85_CR29","doi-asserted-by":"crossref","first-page":"2456","DOI":"10.1001\/jama.2015.6358","volume":"313","author":"PF Whiting","year":"2015","unstructured":"Whiting PF, Wolff RF, Deshpande S et\u00a0al (2015) Cannabinoids for medical use: a systematic review and meta-analysis. JAMA 313:2456. doi: 10.1001\/jama.2015.6358","journal-title":"JAMA"},{"key":"85_CR30","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.baga.2011.04.002","volume":"1","author":"C Zadikoff","year":"2011","unstructured":"Zadikoff C, Wadia PM, Miyasaki J et\u00a0al (2011) Cannabinoid, CB1 agonists in cervical dystonia: failure in a phase\u00a0IIa randomized controlled trial. Basal Ganglia 1:91\u201395. doi: 10.1016\/j.baga.2011.04.002","journal-title":"Basal Ganglia"},{"key":"85_CR31","first-page":"707596","volume":"2015","author":"MW Zhang","year":"2015","unstructured":"Zhang MW, Ho RCM (2015) The cannabis dilemma: a review of its associated risks and clinical efficacy. J\u00a0Addict 2015:707596. doi: 10.1155\/2015\/707596","journal-title":"J\u00a0Addict"},{"key":"85_CR32","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1007\/s00105-005-1063-x","volume":"57","author":"M Zutt","year":"2006","unstructured":"Zutt M, H\u00e4n\u00dfle H, Emmert S et\u00a0al (2006) Dronabinol zur supportiven Therapie metastasierter maligner Melanome mit Lebermetastasen. Hautarzt 57:423\u2013427. doi: 10.1007\/s00105-005-1063-x","journal-title":"Hautarzt"}],"container-title":["Der Schmerz"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00482-015-0085-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00482-015-0085-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00482-015-0085-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T21:28:13Z","timestamp":1559078893000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00482-015-0085-2"}},"subtitle":["Systematische \u00dcbersicht und Metaanalyse der Wirksamkeit, Vertr\u00e4glichkeit und Sicherheit","Systematic review and meta-analysis of efficacy, tolerability and safety"],"short-title":[],"issued":{"date-parts":[[2016,1,25]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,2]]}},"alternative-id":["85"],"URL":"https:\/\/doi.org\/10.1007\/s00482-015-0085-2","relation":{},"ISSN":["0932-433X","1432-2129"],"issn-type":[{"value":"0932-433X","type":"print"},{"value":"1432-2129","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,1,25]]}}}